4
Changes in Ownership
Anebulo Pharmaceuticals, Inc. Filed Acc 0001209191-22-061093
Options or other derivatives
- Chief Scientific Officer acquired 35,017 shares (grant or award)
From the SEC's structured data for this filing
Anebulo Pharmaceuticals, Inc. Filed Acc 0001209191-22-061093
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…